$Audit support : Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab : Implementing NICE guidance$
Cover image not available

Audit support : Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab : Implementing NICE guidance

National Institute for Health and Clinical Excellence

Publication Data

Title Audit support : Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab : Implementing NICE guidance
Alternative Title Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 2010
Publication location London
Language English

Descriptive Notes

"Technology appraisal implementation tools."

Topics

Chronic lymphocytic leukemia :: Chemotherapy :: Evaluation
Medical audit
Monoclonal antibodies

Catalogue Data

OBNB ID GBB586368
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99419061

ISBD

P1053 1 online resource (6 pages).
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Audit support : Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab : Implementing NICE guidance by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2010. Publication and catalogue information, links to buy online and reader comments.